Skip to main content
. 2023 May 2;42(23):1875–1888. doi: 10.1038/s41388-023-02705-7

Table 1.

FGFR VUS variants characterised as oncogenic or likely oncogenic using an in vitro high-throughput transformation assay (MANO method).

Likely oncogenic Oncogenic
FGFR1 N546K; K656E K656M
FGFR2 C62Y; N82K; E160K; E163K; Q212K; A264T; K310R; R399X; H416R; I422V; H544Q; L560F; S791T A67V; D101Y; Y328N; G364E; V392A; E718K
FGFR3 H284fs*10 R248 S249insC; K650Q